Getinge Interim Report April-June 2024: Higher sales, stronger margins and product launches with significant added value for customers
GOTHENBURG, Sweden, July 18, 2024 /PRNewswire/ -- "Net sales increased by 15.7% in the second quarter, of which the organic increase was 8.9%," says Mattias Perjos, President & CEO at Getinge. "The operating margin improved compared with last year due to strong sales and a positive product mix, w...
Getinge's financial target 2024-2028: Adjusted EPS growth of above 12% on average
GOTHENBURG, Sweden, May 15, 2024 /PRNewswire/ -- Getinge updates its financial target for adjusted EPS growth 2024-2028 to be above 12% on average. The target takes into account today's decisions (see below) that follow from the letter that the U.S. Food and Drug Administration (FDA) sent to heal...
Getinge accelerates growth and productivity to reach new financial targets
GOTHENBURG, Sweden, Nov. 22, 2021 /PRNewswire/ -- "Getinge's new financial targets for 2022-2025, an annual organic net sales growth of 4-6% and adjusted EPS growth of above 10% on average throughout the period, is well in line with our strategy and ambitions", says Mattias Perjos, President & CE...
Getinge Interim Report January-June 2021: Strong recovery in products for surgery
GETINGE, Sweden, July 16, 2021 /PRNewswire/ -- "In total, sales increased by 3.6% organically compared with the second quarter 2020, and the order intake declined by 6.1% organically compared with 2020 when we received very large orders of advanced ICU ventilators", says Mattias Perjos, President...
